The NNI has just released its 2014 draft Strategic Plan for public comment. Aside from the opportunity to submit comments, becoming familiar with the plan offers a number of benefits to nanotech ventures. One is that it provides a useful overview of the agencies involved, which can make it easier to identify potential soures of government funding. It is easy to get lost in government alphabet soup, but this document explains the roles of various agencies and shows their areas of focus. For example, the report provides a link to “Nanotech Signature Initiatives” (NSI’s), which are a high priority from the government’s perspective for development. These areas include nanoscale solar energy collection and conversion, sustainable nanomanufacturing, and nanoelectronics. More info about NSI’s is found here. Another benefit of reviewing the plan is that it provides case studies of successful commercialization of nanotechnology. Insights from a number of different studies is provided in appendices near the end of the plan.
Related Insights
02 June 2025
Events
Biotech Panel Discussion & Happy Hour
Join Foley & Lardner LLP along with Biotech XYZ for an engaging evening event featuring a dynamic panel discussion and a lively happy hour.
03 June 2025
Events
Biotech Breakfast + Office Hours
Join Foley & Lardner LLP along with Biotech XYZ for Phase Capitals’ flagship networking biotech breakfast and office hours with Q&A sessions.
30 June 2025
Events
AHLA Annual Meeting
Foley partners Judy Waltz, chair of the firm’s Health Care Practice Group, and Leah D'Aurora Richardson are speaking in the American Health Law Association’s (AHLA) Annual Meeting in San Diego, CA. Waltz is hosting the session “Evolving Expectations: Medicare Advantage Compliance for Plans and Providers,” and Richardson is speaking in the session “Getting Aligned: Structuring Strategic Affiliations for Community Providers.”